Trials / Unknown
UnknownNCT02369107
The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting
A Multi-center,Randomized Controlled Clinical Trial: the Effect of Acupuncture in Prevention and Treatment of Chemotherapy-induced Nausea and Vomiting on Patients With Malignancy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Nausea and vomiting are the most common symptoms experienced by cancer patients after chemotherapy. Some patients have to endure such unpleasant symptoms even after using of antiemetic or anti-vomiting medications.The purpose of this study is to assess the therapeutic effects and safety of acupuncture for chemotherapy-induced nausea and vomiting on patients with malignancy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Verum acupuncture and medicine | Participants will receive acupuncture therapy 1 hour prior to chemotherapy administration ,6 hours after chemotherapy administration,and once acupuncture therapy on the following day2,3,4,5. The stimulation points are RN12,LR13(bilaterally), RN6, ST25(bilaterally), PC6(bilaterally), ST36(bilaterally). The acupuncture needle in ST36 and auxiliary point will be connected to form a circuit containing a SDZ-V stimulator for 30 min with a frequency of 2/100 Hz. They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total). |
| OTHER | Sham acupuncture and medicine | Participants will receive minimal acupuncture therapy at the same time as the intervention group .The stimulation points are not belong to traditional Chinese medicine.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total). |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-12-01
- Completion
- 2016-12-01
- First posted
- 2015-02-23
- Last updated
- 2015-02-23
Source: ClinicalTrials.gov record NCT02369107. Inclusion in this directory is not an endorsement.